- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aspen Pharmacare Holdings Ltd (APNJ)
Aspen Pharmacare Holdings Ltd stock price live, this page displays JO APNJ stock exchange data. View the APNJ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aspen Pharmacare Holdings Ltd real time stock price chart below.
What Is the Aspen Pharmacare Holdings Ltd Stock Price Today?
The Aspen Pharmacare Holdings Ltd stock price today is 10,300.
What Is the Stock Symbol for Aspen Pharmacare Holdings Ltd?
The stock symbol for Aspen Pharmacare Holdings Ltd is ""APNJ.""
What Stock Exchange Does Aspen Pharmacare Holdings Ltd Trade On?
Aspen Pharmacare Holdings Ltd is listed and trades on the Johannesburg stock exchange.
Is Aspen Pharmacare Holdings Ltd a Good Stock to Buy?
Determining whether Aspen Pharmacare Holdings Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APNJ quote. (ISIN: ZAE000066692)
What Is the Aspen Pharmacare Holdings Ltd Stock Price Today?
The Aspen Pharmacare Holdings Ltd stock price today is 10,300.
What Is the Stock Symbol for Aspen Pharmacare Holdings Ltd?
The stock symbol for Aspen Pharmacare Holdings Ltd is ""APNJ.""
What Stock Exchange Does Aspen Pharmacare Holdings Ltd Trade On?
Aspen Pharmacare Holdings Ltd is listed and trades on the Johannesburg stock exchange.
Is Aspen Pharmacare Holdings Ltd a Good Stock to Buy?
Determining whether Aspen Pharmacare Holdings Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the APNJ quote. (ISIN: ZAE000066692)
10,300
-93(-0.89%)
Closed·
Fair Value
An estimate of a Aspen Pharmacare Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10,247
10,607
52 wk Range
9,315
20,000
APNJ Scorecard
Full Analysis
Has raised its dividend for 4 consecutive years
APNJ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Aspen Pharmacare Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10,24710,607
52 wk Range
9,31520,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.03%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.03%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
APNJ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aspen Pharmacare Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
12,380
Upside
+20.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Aspen Pharmacare Holdings Ltd Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Compare APNJ to Peers and Sector
Metrics to compare | APNJ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAPNJPeersSector | |
|---|---|---|---|---|
P/E Ratio | −42.3x | 11.0x | −0.6x | |
PEG Ratio | 0.34 | 0.44 | 0.00 | |
Price/Book | 0.5x | 1.8x | 2.6x | |
Price / LTM Sales | 1.1x | 1.2x | 3.3x | |
Upside (Analyst Target) | 17.0% | 8.6% | 38.0% | |
Fair Value Upside | Unlock | 16.8% | 4.3% | Unlock |
Analyst Ratings
0 Buy
3 Hold
2 Sell
Ratings:
5 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 12,380
(+20.19% Upside)
Earnings
Latest Release
Sep 03, 2025
EPS / Forecast
-7.82 / --
Revenue / Forecast
21.40B / --
People Also Watch
FAQ
What Stock Exchange Does Aspen Pharmacare Holdings Trade On?
Aspen Pharmacare Holdings is listed and trades on the Johannesburg Stock Exchange stock exchange.
What Is the Stock Symbol for Aspen Pharmacare Holdings?
The stock symbol for Aspen Pharmacare Holdings is "APNJ."
What Is the Aspen Pharmacare Holdings Market Cap?
As of today, Aspen Pharmacare Holdings market cap is 45.59B.
What Is Aspen Pharmacare Holdings's Earnings Per Share (TTM)?
The Aspen Pharmacare Holdings EPS (TTM) is -2.44.
From a Technical Analysis Perspective, Is APNJ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aspen Pharmacare Holdings Stock Split?
Aspen Pharmacare Holdings has split 2 times.
How Many Employees Does Aspen Pharmacare Holdings Have?
Aspen Pharmacare Holdings has 9109 employees.
What is the current trading status of Aspen Pharmacare Holdings (APNJ)?
As of 08 Sept 2025, Aspen Pharmacare Holdings (APNJ) is trading at a price of 10,300, with a previous close of 10,393.00. The stock has fluctuated within a day range of 10,247 to 10,607, while its 52-week range spans from 9,315 to 20,000.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.